RG

Redmile Group Portfolio holdings

AUM $1.36B
1-Year Est. Return 111.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+111.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$88.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
48
New
Increased
Reduced
Closed

Top Buys

1
+$9.02M
2
+$7.49M
3
+$1.5M
4
NGNE icon
Neurogene
NGNE
+$449K

Top Sells

1
+$35.1M
2
+$26.4M
3
+$15.5M
4
BHVN icon
Biohaven
BHVN
+$10.3M
5
BSX icon
Boston Scientific
BSX
+$9.16M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRA icon
26
Atara Biotherapeutics
ATRA
$39.1M
$6.33M 0.62%
441,701
FOLD icon
27
Amicus Therapeutics
FOLD
$4.51B
$6.12M 0.6%
777,178
-411,820
ALXO icon
28
ALX Oncology
ALXO
$277M
$6.1M 0.59%
3,332,983
-58,472
ESTA icon
29
Establishment Labs
ESTA
$2.29B
$5.3M 0.52%
129,364
-7,131
CBLL
30
CeriBell Inc
CBLL
$693M
$5M 0.49%
435,239
XERS icon
31
Xeris Biopharma Holdings
XERS
$1.02B
$3.67M 0.36%
451,099
VTYX icon
32
Ventyx Biosciences
VTYX
$1B
$3.34M 0.32%
1,073,386
-41,143
LVTX
33
DELISTED
LAVA Therapeutics
LVTX
$3.24M 0.31%
2,074,372
RPTX
34
DELISTED
Repare Therapeutics
RPTX
$2.79M 0.27%
1,586,174
IVVD icon
35
Invivyd
IVVD
$477M
$2.51M 0.24%
2,285,320
PLRX icon
36
Pliant Therapeutics
PLRX
$79.9M
$2.36M 0.23%
1,591,695
-40,882
REPL icon
37
Replimune Group
REPL
$632M
$2.25M 0.22%
535,818
-4,128,973
PRME icon
38
Prime Medicine
PRME
$834M
$483K 0.05%
87,118
-1,987,232
KLRS
39
Kalaris Therapeutics
KLRS
$196M
$479K 0.05%
82,955
BOLD
40
Boundless Bio
BOLD
$26M
$302K 0.03%
245,458
-343,576
VERV
41
DELISTED
Verve Therapeutics
VERV
– –
-740,261
HNGE
42
Hinge Health
HNGE
$3.37B
– –
-300,000
BHVN icon
43
Biohaven
BHVN
$1.53B
– –
-729,515
BSX icon
44
Boston Scientific
BSX
$114B
– –
-85,301
FDMT icon
45
4D Molecular Therapeutics
FDMT
$493M
– –
-112,168
IGMS
46
DELISTED
IGM Biosciences
IGMS
– –
-2,952,131
KYMR icon
47
Kymera Therapeutics
KYMR
$7.31B
– –
-803,289
PEN icon
48
Penumbra
PEN
$13.5B
– –
-18,818
1
2